Jee, W S; Ma, Y F (1997) The in vivo anabolic actions of prostaglandins in bone. Bone 21:297-304
|
Ma, Y F; Lin, B Y; Jee, W S et al. (1997) Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats. J Bone Miner Res 12:267-75
|
Ma, Y; Jee, W S; Chen, Y et al. (1995) Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats. J Bone Miner Res 10:1726-34
|
Liang, H H; Ma, Y F; Jee, W S et al. (1995) Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats. Bone 17:335S-339S
|
Lin, C H; Jee, W S; Ma, Y F et al. (1995) Early effects of prostaglandin E2 on bone formation and resorption in different bone sites of rats. Bone 17:255S-259S
|
Pan, Z; Jee, W S; Ma, Y F et al. (1995) Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats. Bone 17:291S-296S
|
Ijiri, K; Ma, Y F; Jee, W S et al. (1995) Adaptation of non-growing former epiphysis and metaphyseal trabecular bones to aging and immobilization in rat. Bone 17:207S-212S
|
Li, M; Jee, W S; Ke, H Z et al. (1995) Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats. J Bone Miner Res 10:66-73
|
Jee, W S; Ma, Y F; Chow, S Y (1995) Maintenance therapy for added bone mass or how to keep the profit after withdrawal of therapy of osteopenia. Bone 17:309S-319S
|
Yuan, Z Z; Jee, W S; Ma, Y F et al. (1995) Parathyroid hormone therapy accelerates recovery from immobilization-induced osteopenia. Bone 17:219S-223S
|
Showing the most recent 10 out of 56 publications